Fulltext present in this item

Thumbnail
Fulltext: 179606.pdf
Format: PDF
Description: publisher's version
Embargo: until further notice
Title: Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease
Author(s): Plantinga, T.S. ; Arts, P.; Knarren, G.H.; Mulder, A.H.; Wakelkamp, I.M.; Hermus, A.R.M.M. ; Joosten, L.A. ; Netea, M.G. ; Gilissen, C.F. ; Veltman, J.A. ; Hoischen, A. ; Smit, J.W.A. ; Netea-Maier, R.T.
Publication year: 2017
Source: Clinical Pharmacology and Therapeutics, vol. 102, iss. 6, (2017), pp. 1017-1024
ISSN: 0009-9236
DOI: https://doi.org/10.1002/cpt.733
Publication type: Article / Letter to editor

Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/179606   https://hdl.handle.net/2066/179606

Display more details
Subject: All institutes and research themes of the Radboud University Medical Center
Radboudumc 16: Vascular damage RIHS: Radboud Institute for Health Sciences
Radboudumc 18: Healthcare improvement science RIHS: Radboud Institute for Health Sciences
Radboudumc 4: lnfectious Diseases and Global Health RIMLS: Radboud Institute for Molecular Life Sciences
Radboudumc 6: Metabolic Disorders RIMLS: Radboud Institute for Molecular Life Sciences
Radboudumc 7: Neurodevelopmental disorders DCMN: Donders Center for Medical Neuroscience
Radboudumc 9: Rare cancers RIMLS: Radboud Institute for Molecular Life Sciences
Organization: Pathology
Human Genetics
Internal Medicine
Journal title:
Clinical Pharmacology and Therapeutics
Volume: vol. 102
Issue: iss. 6
Page start: p. 1017
Page end: p. 1024

This item appears in the following Collection(s)

Browse

Statistics